Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 561-570 of 686 for Cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Metabolic Agents Pharmacodynamic Analyses After Brain Radiation

    Rochester, MN

  2. A Study to Develop and Maintain a Registry of Specimens from Patients with Bladder Cancer

    Jacksonville, FL

  3. Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

    Rochester, MN

  4. Congenital Heart Disease Skin Punch Biopsy Sample Collection

    Rochester, MN

  5. Fertility Outcomes in Lymphoma Patients

    Jacksonville, FL

  6. MElanoma Research Lymph node prediction Implementation National_001 (MERLIN_001)

    Rochester, MN

  7. A Study to Create a Registry for Patients at High-Risk for Pancreatic Cancer

    Rochester, MN

  8. Defining the Immunologic Profile of Sentinel Lymph Nodes and Identifying the Mechanisms Responsible for Immunosuppression

    Rochester, MN, Jacksonville, FL

  9. Patient Derived Preclinical Models

    Rochester, MN

  10. Screening for High Frequency Malignant Disease

    Jacksonville, FL

.

Mayo Clinic Footer